Form 4: Boston Scientific EVP Arthur C. Butcher Reports Stock Transactions
SEC Form 4 Filing
Arthur C. Butcher, EVP & Group President at Boston Scientific, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- Arthur C. Butcher, an Executive Vice President at Boston Scientific, filed a Form 4 detailing changes in beneficial ownership.
- On May 2, 2024, Butcher acquired 2,102 shares of common stock through the vesting of restricted stock units.
- On the same day, Butcher disposed of 1,017 shares of common stock to cover tax obligations, at a price of $72.03 per share.
- Following these transactions, Butcher directly owns 30,022 shares of common stock and indirectly owns 2,539 shares through a 401(k) plan.
- Butcher also directly owns 4,204 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive stock transactions, and doesn't inherently indicate positive or negative sentiment. It reflects standard compensation practices.
Future Outlook
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023.
Industry Context
Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's performance and future prospects. Form 4 filings are a standard part of regulatory compliance for corporate insiders.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are common across the medical device industry.
- Companies like Medtronic (MDT) and Abbott Laboratories (ABT) also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and terms of these equity grants are typically benchmarked against industry peers to ensure competitiveness.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation adjustments.
- Employees participating in the 401(k) plan may be indirectly affected by the changes in share holdings.
Key Dates
| Date | Description |
|---|---|
| 05/02/2023 | First anniversary of the date of grant for restricted stock units. |
| 05/02/2024 | Date of stock acquisition and disposal. |
| 05/02/2026 | Expiration date for restricted stock units. |
| 05/06/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.